🇺🇸 FDA
Patent

US 8604058

4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

granted A61KA61K31/4465A61P

Quick answer

US patent 8604058 (4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds) held by Theravance, Inc. expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/4465, A61P, A61P11/06, A61P13/00